Dapsone- and primaquine-induced methemoglobinemia in HIV-infected individuals

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 12, Issue 5, 1996, Pages 477-481

  Sin, Don D ^a   Shafran, Stephen D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Dapsone; Methemoglobinemia; Primaquine

Indexed keywords

DAPSONE; METHEMOGLOBIN; METHYLENE BLUE; PRIMAQUINE;

ADULT; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CASE REPORT; CELL DEATH; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOXEMIA; LYMPHOCYTE COUNT; MALE; METHEMOGLOBINEMIA; OXYGEN THERAPY; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL;

HUMAN IMMUNODEFICIENCY VIRUS; PNEUMOCYSTIS CARINII;

EID: 0029815588     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199608150-00006     Document Type: Article

References (28)

1. Mansouri A, Aubrey A. Concise review; methemoglobinemia. Am J Hematol 1993;42:7-12.
2. Cooke TJL. Dapsone poisoning. Med J Aust 1970;1:1158-9.
3. Nagel RL. Disorders of hemoglobin function and stability. In: Blood: principles and practice of hematology. Philadelphia: J. B. Lippincott, 1995:1631.
4. Smith RP, Olson MV. Drug-induced methemoglobinemia. Semin Hematol 1973;10:253-68.
5. Webster LT Jr. Drugs used in the chemotherapy of protozoal infections: malaria. In: Goodman and Gilman's the pharmacological basis of therapeutics, 8th ed. New York: Pergamon Press, 1990:978-98.
6. Torres RA, Barr M, Thorm M, et al. Randomized trial of dapsone and aerosolized pentamidine for the prophylaxis of Pneumocystis carinii pneumonia and toxoplasmic encephalitis. Am J Med 1993;95:573-83.
7. Medina I, Mills J, Leung G, et ai. Oral therapy for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome: a controlled trial of trimethoprim-sulfamethoxazole versus trimethoprim-dapsone. N Engl J Med 1990;373:776-82.
8. Toma E, Poisson M, Phaneuf D, Fourier S, Morisset R, Vega C. Clindamycin and primaquine for Pneumocystis carinii pneumonia. Lancet 1989;1:1046-8.
9. Dawson AH, Whyte IM. Management of dapsone poisoning complicated by methemoglobinemia. Med Toxicol Adverse Drug Exp 1989;4:387-92.
10. Reiter WM, Cimoch PJ. Dapsone-induced methemoglobinemia in a patient with Pneumocystis carinii pneumonia and AIDS. N Engl J Med 1987;27:1740-1 (letter).
11. Ruf B, Pohle HD. Clindamycin/primaquine for Pneumocystis carinii pneumonia. Lancet 1989;2:626-7 (letter).
12. Kantor GS. Primaquine-induced methemoglobinemia during treatment of Pneumocystis carinii pneumonia. N Engl J Med 1992;327:1461 (letter).
13. Woodhouse KW, Henderson DB, Charlton B, et al. Acute dapsone poisoning: clinical features and pharmacokinetic studies. Hum Toxicol 1983;3:507-10.
14. Curry S. Methemoglobinemia. Ann Emerg Med 1982;11: 214-21.
15. Taylor AE, Rehder K, Hyatt RE, et al. Gas transport in the blood. In: Clinical respiratory physiology. Philadelphia: W. B. Saunders, 1989:53.
16. Erstad BL. Dapsone-induced methemoglobinemia and hemolytic anemia. Clin Pharm 1992;11:800-5.
17. Staal FJT, Ela SW, Roederer M, et al. Glutathione deficiency and human immunodeficiency virus infection. Lancet 1992;339:909-12.
18. Hansen DG, Challoner KR, Smith DE. Dapsone intoxication: two case reports. J Emerg Med 1994;12:347-51.
19. Ahmad RA, Rogers HJ. Pharmacokinetics and protein binding of dapsone and pyrimethamine. Br J Clin Pharmacol 1980;10:519-24.
20. Kramer PA,Glader BE, Li TK. Mechanism of methemoglobin formation by diphenylsulphones. Biochem Pharmacol 1972;21:1265-74.
21. Zuidema J, Hilbers-Modderman ESM, Merkus FWHM. Clinical pharmacokinetics of dapsone. Clin Pharmacokin 1986;11:299-315.
22. Watcha MF, Connor MD, Hing AV. Pulse oximetry in methemoglobinemia. AJDC 1989;143:845-67.
23. Alexander CM, Teller L, Gross J. Principles of oximetry: theoretical and practical considerations. Anesth Analg 1989; 68:368.
24. Wiedemann HP, McCarthy K. Noninvasive monitoring of oxygen and carbon dioxide. Clin Chest Med 1989;10:239-53.
25. Mitchell R, Hoffman PC. Anemia, leukopenia, elevated blood counts. In: Principles of critical care. New York: Mc-Graw-Hill, 1992:1807-17.
26. Neuvonen PJ, Elonen E, Mattila MJ. Oral activated charcoal and dapsone elimination. Clin Pharmacol Ther 1980;27: 823-7.
27. Harris JC. Rumack BH, Peterson RG, et al. Methemoglobinemia resulting from absorption of nitrates. JAMA 1979;242: 2869-71.
28. Goluboff N, Wheaton R. Methylene blue induced cyanosis and acute hemolytic anemia complicating the treatment of methemoglobinemia. J Pediatr 1961;58:86.